Gene · 1291
Papers2,357
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,357
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| c-JUN is a barrier in hESC to cardiomyocyte transition. | Life Sci Alliance | 2023 | 37604584 | PubTator, text mining | PubMed |
| Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. | Mol Syst Biol | 2023 | 37602975 | PubTator, text mining | PubMed |
| Precision medicine using whole genome sequencing in a cat identifies a novel COL5A1 variant for classical Ehlers-Danlos syndrome. | J Vet Intern Med | 2023 | 37594181 | PubTator, text mining | PubMed |
| Splicing defects in rare diseases: transcriptomics and machine learning strategies towards genetic diagnosis. | Brief Bioinform | 2023 | 37580177 | PubTator, text mining | PubMed |
| Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups. | Ann Rheum Dis | 2023 | 37580109 | PubTator, text mining | PubMed |
| A Scd1-mediated metabolic alteration participates in liver responses to low-dose bavachin. | J Pharm Anal | 2023 | 37577386 | PubTator, text mining | PubMed |
| Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. | Front Immunol | 2023 | 37575263 | PubTator, text mining | PubMed |
| Co-inhibition of glutaminolysis and one-carbon metabolism promotes ROS accumulation leading to enhancement of chemotherapeutic efficacy in anaplastic thyroid cancer. | Cell Death Dis | 2023 | 37573361 | PubTator, text mining | PubMed |
| New Clinical and Immunofluoresence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients. | Int J Mol Sci | 2023 | 37569848 | PubTator, text mining | PubMed |
| The Bladder Tumor Microenvironment Components That Modulate the Tumor and Impact Therapy. | Int J Mol Sci | 2023 | 37569686 | PubTator, text mining | PubMed |
| Novel Variant IMPDH1 c.134A>G, p.(Tyr45Cys): Phenotype-Genotype Correlation Revealed Likely Benign Clinical Significance. | Int J Mol Sci | 2023 | 37569264 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-neural progenitors are enriched in cell signaling molecules implicated in their therapeutic effect in multiple sclerosis. | PLoS One | 2023 | 37566599 | PubTator, text mining | PubMed |
| Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy. | Cells | 2023 | 37566027 | PubTator, text mining | PubMed |
| Decoding the molecular crosstalk between grafted stem cells and the stroke-injured brain. | Cell Rep | 2023 | 37561627 | PubTator, text mining | PubMed |
| Dynamic human retinal pigment epithelium (RPE) and choroid architecture based on single-cell transcriptomic landscape analysis. | Genes Dis | 2023 | 37554187 | PubTator, text mining | PubMed |
| Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma. | BMC Med | 2023 | 37553571 | PubTator, text mining | PubMed |
| SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling. | Front Immunol | 2023 | 37545510 | PubTator, text mining | PubMed |
| Hepatic transcript profiling in beef cattle: Effects of rumen-protected niacin supplementation. | PLoS One | 2023 | 37535643 | PubTator, text mining | PubMed |
| Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal Ligaments. | Curr Osteoporos Rep | 2023 | 37530996 | PubTator, text mining | PubMed |
| Transcriptome-Wide Studies of RNA-Targeted Small Molecules Provide a Simple and Selective r(CUG)exp Degrader in Myotonic Dystrophy. | ACS Cent Sci | 2023 | 37521782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1291/papers?page=15